CA
NZ
UK
AU
IND
US
…
Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Doximity operates a professional network and workflow platform for U.S. healthcare professionals, providing communication, telehealth, recruiting and marketing tools. Long-term growth may be supported by increasing digitalization of clinical workflows, telehealth adoption and demand for targeted pharmaceutical marketing and recruitment, while network effects and recurring revenue could support monetization.
Key investment risks include regulatory and data-privacy compliance, dependence on pharmaceutical ad and hiring budgets, and competition or execution failures that could weaken user engagement or revenue.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | 263.57M | 185.20M | 133.16M | 114.00M | 57.77M |
| Net income | 223.19M | 147.58M | 112.82M | 154.78M | 50.21M |
| Selling general administrative | 45.67M | 37.83M | 36.74M | 35.75M | 16.49M |
| Selling and marketing expenses | 145.71M | 133.13M | 123.52M | 92.13M | 62.03M |
| Gross profit | 514.52M | 424.75M | 365.56M | 303.76M | 175.70M |
| Reconciled depreciation | 10.66M | 10.27M | 10.28M | 5.04M | 3.70M |
| Ebit | 230.10M | 171.81M | 125.11M | 113.54M | 53.30M |
| Ebitda | 240.76M | 182.08M | 135.39M | 118.58M | 57.01M |
| Depreciation and amortization | 10.66M | 10.27M | 10.28M | 5.04M | 3.70M |
| Operating income | 227.80M | 163.88M | 125.11M | 113.54M | 53.30M |
| Other operating expenses | 342.60M | 311.54M | 293.94M | 230.01M | 153.59M |
| Interest expense | - | - | 8.05M | 0.47M | 4.47M |
| Tax provision | 40.39M | 37.62M | 20.34M | -40.78M | 7.56M |
| Interest income | 35.85M | 21.66M | - | - | 0.30M |
| Net interest income | 35.85M | 21.66M | - | - | 0.30M |
| Income tax expense | 40.39M | 37.62M | 20.34M | -40.78M | 7.56M |
| Total revenue | 570.40M | 475.42M | 419.05M | 343.55M | 206.90M |
| Total operating expenses | 286.73M | 260.88M | 240.45M | 190.22M | 122.40M |
| Cost of revenue | 55.87M | 50.67M | 53.49M | 39.79M | 31.20M |
| Total other income expense net | 35.77M | 21.32M | 8.05M | 0.47M | 4.47M |
| Net income from continuing ops | 223.19M | 147.58M | 112.82M | 154.78M | 50.21M |
| Net income applicable to common shares | - | - | 112.82M | 176.31M | 21.56M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 1264.31M | 1079.37M | 1136.89M | 991.36M | 251.72M |
| Intangible assets | 23.07M | 27.32M | 31.84M | 7.91M | 9.60M |
| Other current assets | 44.60M | 48.71M | 22.29M | 24.95M | 10.69M |
| Total liab | 181.68M | 177.98M | 170.77M | 112.76M | 184.98M |
| Total stockholder equity | 1082.62M | 901.40M | 966.12M | 878.59M | 66.74M |
| Other current liab | 37.05M | 29.68M | 31.25M | 25.27M | 16.29M |
| Common stock | 0.19M | 0.19M | 0.19M | 0.19M | 0.08M |
| Capital stock | 0.19M | 0.19M | 0.19M | 0.19M | 0.08M |
| Retained earnings | 186.89M | 79.99M | 217.85M | 191.11M | 36.32M |
| Other liab | - | - | 17.38M | 1.03M | 1.19M |
| Good will | 67.94M | 67.94M | 67.94M | 18.91M | 18.91M |
| Other assets | - | - | - | 50.82M | 4.87M |
| Cash | 209.61M | 96.78M | 158.03M | 112.81M | 66.39M |
| Total current liabilities | 156.26M | 147.25M | 139.51M | 111.28M | 102.04M |
| Current deferred revenue | 114.28M | 99.14M | 105.24M | 84.91M | 83.27M |
| Net debt | -197.22M | -82.24M | -142.39M | -111.72M | -65.14M |
| Short term debt | 2.21M | 2.15M | 1.75M | 0.64M | 0.97M |
| Short long term debt total | 12.40M | 14.55M | 15.64M | 1.09M | 1.25M |
| Other stockholder equity | 894.23M | 823.88M | 762.15M | -288.77M | 30.36M |
| Property plant equipment | - | - | 25.10M | 9.57M | 8.94M |
| Total current assets | 1088.62M | 912.94M | 975.45M | 904.14M | 209.40M |
| Net tangible assets | - | - | - | 851.77M | 38.23M |
| Short term investments | 706.05M | 666.12M | 682.97M | 685.30M | 76.14M |
| Net receivables | 128.35M | 101.33M | 107.05M | 81.07M | 50.32M |
| Inventory | - | -42.61M | 5.12M | - | 5.86M |
| Accounts payable | 1.36M | 2.25M | 1.27M | 0.46M | 1.51M |
| Accumulated other comprehensive income | 1.32M | -2.66M | -14.08M | -15.29M | -0.02M |
| Common stock total equity | - | - | - | - | 0.08M |
| Non currrent assets other | 2.12M | 1.46M | 1.65M | 2.26M | 2.76M |
| Non current assets total | 175.69M | 166.43M | 161.44M | 87.22M | 42.32M |
| Capital lease obligations | 12.40M | 14.55M | 15.64M | 1.09M | 1.25M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | -29.30M | 31.19M | -59.92M | -635.47M | -38.34M |
| Change to liabilities | - | - | 17.53M | 10.49M | 38.66M |
| Total cashflows from investing activities | -29.30M | 31.19M | -59.92M | -640.57M | -70.42M |
| Total cash from financing activities | -131.14M | -276.52M | -74.46M | 560.41M | 5.41M |
| Change to operating activities | - | - | -12.12M | -19.80M | -8.18M |
| Net income | 223.19M | 147.58M | 112.82M | 154.78M | 50.21M |
| Change in cash | 112.83M | -61.24M | 45.22M | 46.42M | 17.96M |
| Begin period cash flow | 96.78M | 158.03M | 112.81M | 66.39M | 48.43M |
| End period cash flow | 209.61M | 96.78M | 158.03M | 112.81M | 66.39M |
| Total cash from operating activities | 273.26M | 184.10M | 179.60M | 126.58M | 82.97M |
| Issuance of capital stock | - | 0.00M | 0.00M | 553.90M | - |
| Depreciation | 10.66M | 10.27M | 10.28M | 5.04M | 3.70M |
| Other cashflows from investing activities | -6.53M | -5.65M | - | 0.59M | -0.01M |
| Change to inventory | - | - | - | - | 1.21M |
| Change to account receivables | -27.21M | 3.99M | -26.24M | -31.02M | -20.45M |
| Sale purchase of stock | -120.29M | -280.72M | -85.32M | -2.70M | -2.02M |
| Other cashflows from financing activities | -34.15M | 4.19M | 10.86M | 9.21M | 7.43M |
| Change to netincome | - | - | - | -2.67M | 12.14M |
| Capital expenditures | 6.53M | 5.80M | 6.18M | 5.70M | 4.61M |
| Change in working capital | -24.10M | -24.52M | -21.03M | -40.33M | 10.03M |
| Stock based compensation | 72.39M | 51.08M | 47.83M | 31.44M | 7.25M |
| Other non cash items | 2.72M | 8.29M | 16.47M | 16.89M | 6.79M |
| Free cash flow | 266.74M | 178.29M | 173.42M | 120.88M | 78.36M |
Sector: Healthcare Industry: Health Information Services
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| DOCS Doximity Inc |
0.31 1.19% |
26.35 | 20.29 | 15.43 | 7.13 | 4.60 | 5.93 | 15.01 |
| VEEV Veeva Systems Inc Class A |
5.84 2.12% |
280.68 | 43.49 | 29.59 | 12.48 | 5.79 | 10.39 | 33.41 |
| PMCUF Pro Medicus Limited |
- -% |
114.56 | 64.90 | 90.91 | 49.11 | 38.05 | 65.12 | 83.47 |
| TEM Tempus AI, Inc. Class A Common Stock |
2.77 3.37% |
85.01 | - | - | 8.68 | 25.39 | 8.33 | - |
| MTHRY M3 Inc |
0.21 3.90% |
5.59 | 31.84 | 26.25 | 0.05 | 4.60 | 0.04 | 0.12 |
Doximity, Inc. operates as a digital platform for medical professionals in the United States. Its platform provides its members with digital tools built for medicine, that enables its members to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
| Name | Title | Year Born |
|---|---|---|
| Mr. Jeffrey A. Tangney | Co-Founder, CEO & Chairperson | 1973 |
| Ms. Anna Bryson | Chief Financial Officer | 1990 |
| Mr. Paul Jorgensen | Chief Revenue Officer | 1970 |
| Dr. Nate Gross M.D. | Co-Founder & Chief Strategy Officer | NA |
| Ms. Shari Buck | Co-founder and SVP People & Ops | NA |
| Mr. Jey Balachandran | Chief Technology Officer | NA |
| Mr. Perry Scott Gold | Head of Investor Relations | NA |
| Ms. Jennifer W. Chaloemtiarana | Gen. Counsel & Corp. Sec. | 1968 |
| Jim Rivas | Head of Corp. Communications | NA |
| Mr. Bruno Miranda | Sr. VP of Engineering | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.18%
Communication Services
+0.02%
Consumer Cyclical
+0.43%
Consumer Defensive
+0.03%
Energy
-0.27%
Financial Services
+0.32%
Financials
-0.23%
Healthcare
-0.17%
Industrials
+0.45%
Real Estate
-0.02%
Technology
+0.20%
Utilities
+0.20%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...